Alerts will be sent to your verified email
Verify Email
KOBO
|
Kobo Biotech
|
Hemo Organic
|
Hind Bio Science
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-1.77 % | -361.35 % | -24.99 % |
|
5yr average Equity Multiplier
|
4.06 | -1.56 | 3.76 |
|
5yr Average Asset Turnover Ratio
|
0.54 | 0.14 | 0.25 |
|
5yr Avg Net Profit Margin
|
-3.79 % | -763.22 % | -39.56 % |
|
Price to Book
|
0.0 | 0.0 | 6.98 |
|
P/E
|
0.0 | 50.0 | 263.1 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 100.48 Days | 197.57 Days |
|
Inventory Days
|
89.28 Days | 406.93 Days | 0.0 |
|
Days Receivable
|
0.0 | 196.55 Days | 198.39 Days |
|
Days Payable
|
147.48 Days | 2776.86 Days | 104.32 Days |
|
5yr Average Interest Coverage Ratio
|
0.99 | -250.54 | -32.49 |
|
5yr Avg ROCE
|
11.79 % | 37.52 % | -14.28 % |
|
5yr Avg Operating Profit Margin
|
8.83 % | -745.72 % | -38.68 % |
|
5 yr average Debt to Equity
|
1.62 | -0.73 | 2.68 |
|
5yr CAGR Net Profit
|
n/a | n/a | n/a |
|
5yr Average Return on Assets
|
-0.89 % | -33.34 % | -8.2 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
44.95 % | 16.85 % | 12.19 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Kobo Biotech
|
Hemo Organic
|
Hind Bio Science
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|